The picks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The picks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shawn Murphy who wrote (3499)	1/30/1997 10:58:00 PM
From: Amigo Mike	of 6124

Kevin, you posted that you were disappointed with the lack of new picks on the thread lately....... Yesterday morning I posted that Home Depot had fallen to major support at $48. I posted it as a possible call option play and I think 2 people responded to it. I purchased the Feb 50 calls Tuesday afternoon @ 13/16. At the close today the bid is $1. A 23% gain for 1 1/2 days. However I expect that HD will continue up into the $52 - $53 range during the next week. Yesterday the call option volume was high with 1344 contracts traded. HD has fallen to $48 5 times and each time has risen to $53ish. I think it will happen again. AG Edwards has it on the short term trading list over the next 2 months with a target of $59. Check out the chart. New recent acquisition will increase earnings also (earnings due out just before options expiration). It is a good buy up to $51 according to AG Edwards. Stock up 1 1/8 today with monster block trades between 40,000 to 65,000 shares and one for 150,000 (on up tick) a few minutes before close. My pick for the next week. Another pick that will take a little longer is ANTX. I expect move near $2 by early March. I expect at least 3 announcements from ANTX during this time (one about SKB and one announcing positive clinical results and one for new trials beginning). ANTX is developing vaccines against various bacteria like E-coli & Otitis Media which causes ear infections in infants and a bacteria that causes sexually transmitted diseases. They are even developing a vaccine against diarrhea that can be taken in tablet form rather than a shot. Think about going overseas or to Mexico and not have to worry about drinking the water and getting sick. The clinical trials underway are all being paid for by SKB, Pasteur -Merioux, Navy and National Institue of Health. SKB deal is worth $30 million plus future royalties from sales by SKB. This alone is worth more than $1 per share. Short term target is $2 and summer target is near $5. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next